knowledge -WSS

knowledge

author：knowledge 2025-09-27 12:23:08 - browse：4

Illustration of a dollar sign with arrows. — Adobe

Health insurers are telling shareholders that they are ramping up the use of artificial intelligence and are hiring talent to implement the technology across their organizations. They say their artificial intelligence models can increase efficiency and “cut costs,” but they refused to discuss what models they’re using, how those models were developed, or exactly what they’re using them for.

Centene, for instance, says, it is “investing in artificial intelligence and machine learning technologies to improve the health of our members and contain rising healthcare costs.” The insurer, whose plans cover more than 28 million Americans, noted that its large footprint, particularly in government-sponsored programs, puts it “in a unique position to use data to develop models that predict a wide range of health outcomes.”

A STAT review of regulatory filings from publicly traded health insurers showed that several of them, including Elevance, Molina, and Cigna, are investing in AI with the goal of saving money. Elevance has hired nearly 500 people to work exclusively on AI. However, all five of the insurers STAT contacted declined to elaborate on how they are using AI.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Do more moles mean more problems? Not so, says new study

focus

leisure time

WSS

Prosthetic arm enables patients to feel the objects they grip

David Sabatini, ex

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

David Sabatini, ex

Insmed lung disease drug hits target in key Phase 3 trial

FDA needs staff influx to meet gene therapy needs, Marks says

focus

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

What causes an itch? Researchers may have solved the mystery

Medical records are filled with copy

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

ChatGPT in medicine: STAT answers readers' burning questions

What PEPFAR has meant on the ground in Ukraine

Apple is now the first public company to be valued at $3 trillion

Focused ultrasound for uterine fibroids: an uphill battle

Hollywood unions extend contract negotiations for actors

Insmed lung disease drug hits target in key Phase 3 trial

hotspot

Spinal cord stimulation reduces pain in amputees, study finds

Akili, maker of video game for ADHD, to be acquired for 34 million

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Why sickle cell disease is getting the first CRISPR treatment

Childbirth

focus

focus

leisure time

hotspot